Contrast nephropathy.
作者信息
Rezkalla Shereif H
机构信息
Department of Cardiology, Marshfield Clinic, Marshfield, Wisconsin 54449, USA.
出版信息
Clin Med Res. 2003 Oct;1(4):301-4. doi: 10.3121/cmr.1.4.301.
Abstract
Contrast nephropathy will increase mortality up to 30% following angiographic procedures. Before performing such procedures a careful reassessment of the risk/benefit ratio should be performed. Mannitol and diuretics play no role in prevention. Hydration and correction of abnormal electrolyte levels should be done in all patients. Pre-treatment with acetylcysteine and theophylline is a well-accepted strategy and should always be utilized. If creatinine levels are above 2.5 to 3 mg/dl, fenoldopam may provide additional protection, particularly in diabetic patients. However, the role of fenoldopam is controversial. Prophylactic hemodialysis may prove to be an additional tool in the fight against this disease in selected patients.
摘要
相似文献
1
Contrast nephropathy.
Clin Med Res. 2003 Oct;1(4):301-4. doi: 10.3121/cmr.1.4.301.
2
Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
Am Heart J. 2002 May;143(5):894-903. doi: 10.1067/mhj.2002.122118.
3
[Contrast induced nephropathy].
Wien Klin Wochenschr. 2009;121(1-2):15-32. doi: 10.1007/s00508-009-1145-3.
4
Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
Rev Cardiovasc Med. 2001;2 Suppl 1:S26-30.
5
Prevention of radiocontrast-induced nephropathy.
Am J Kidney Dis. 2004 Jul;44(1):12-24. doi: 10.1053/j.ajkd.2004.04.001.
6
Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
Clin Exp Pharmacol Physiol. 2012 Jun;39(6):506-9. doi: 10.1111/j.1440-1681.2012.05709.x.
7
Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Catheter Cardiovasc Interv. 2002 Nov;57(3):279-83. doi: 10.1002/ccd.10323.
8
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.
Ann Intern Med. 2008 Feb 19;148(4):284-94. doi: 10.7326/0003-4819-148-4-200802190-00007.
9
Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).
Int J Cardiol. 2006 May 24;109(3):322-8. doi: 10.1016/j.ijcard.2005.06.038. Epub 2005 Jul 22.
10
A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.
Clin Res Cardiol. 2007 Mar;96(3):130-9. doi: 10.1007/s00392-007-0473-4. Epub 2006 Dec 22.
本文引用的文献
1
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
JAMA. 2003 Nov 5;290(17):2284-91. doi: 10.1001/jama.290.17.2284.
2
Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?
J Am Coll Cardiol. 2003 Mar 5;41(5):725-8. doi: 10.1016/s0735-1097(02)02955-8.
3
Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors.
J Am Coll Cardiol. 2003 Mar 5;41(5):718-24. doi: 10.1016/s0735-1097(02)02956-x.
4
Prevention of contrast nephropathy.
JAMA. 2003 Feb 5;289(5):606-8. doi: 10.1001/jama.289.5.606.
5
Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
JAMA. 2003 Feb 5;289(5):553-8. doi: 10.1001/jama.289.5.553.
6
Time-course of iodine elimination by hemodialysis in patients with renal failure after angiography.
Ther Apher. 2002 Dec;6(6):437-42. doi: 10.1046/j.1526-0968.2002.00469.x.
7
A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
Kidney Int. 2002 Dec;62(6):2202-7. doi: 10.1046/j.1523-1755.2002.00673.x.
8
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
J Am Coll Cardiol. 2002 Oct 16;40(8):1383-8. doi: 10.1016/s0735-1097(02)02308-2.
9
Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review.
Invest Radiol. 2002 Sep;37(9):471-81. doi: 10.1097/01.RLI.0000023572.58117.55.
10
Acetylcysteine and contrast media nephropathy.
Curr Opin Nephrol Hypertens. 2002 Sep;11(5):503-6. doi: 10.1097/00041552-200209000-00005.
Zotero 插件